Search Results

Thor Medical Commences Commercial Supply with First Delivery of High-Purity Thorium-228 from AlphaOne

Thor Medical ASA announced on August 5 that it has completed the first customer delivery of high-purity thorium-228 (Th-228) from its AlphaOne production facility at the Herøya industrial park. This marks the first customer shipment following the facility's production start announced last week, and signifies AlphaOne's entry into the commercial supply phase. Thor Medical CEO Jasper Kurth stated that commercial production represents the beginning of the company's industrial-scale manufacturing, and the first customer delivery demonstrates the company's transition from capacity building to serving customers through its first industrial-scale facility. The company stated that as production capacity gradually ramps up, it will continue to meet the growing demand for high-purity isotopes in the targeted alpha therapy field...

2026-08-06

Quantum X Labs Advances Quantum Computing for Nuclear Particle Transport Predictive Simulations

Quantum X Labs Inc. recently announced that its subsidiary, Nuclear Quantum, has proposed a new solution to a bottleneck in computational simulations for the nuclear industry, attempting to introduce quantum computing into nuclear particle transport prediction to support compute-intensive scenarios such as nuclear medicine system design. According to reports, traditional particle transport simulations play an important role in nuclear medicine system design, but they often require substantial computational resources and involve long runtimes, impacting R&D and optimization efficiency. The technology proposed by Nuclear Quantum aims to transform physical transport models into quantum circuits, enabling particle propagation and random walk dynamics to be directly represented and simulated within a quantum computing framework...

2026-08-06

Leonardo DRS to Build New Facility in Connecticut, U.S. to Support Growth in Naval Nuclear Propulsion-Related Business

Leonardo DRS announced on August 4 that it has signed an agreement to build a new facility in Brookfield, Connecticut, U.S., to expand and consolidate its naval electric power systems operations. The project aims to increase production capacity, support key U.S. Navy-related programs, and provide space and infrastructure for the company's future growth in the nuclear energy sector. According to the company's disclosure, the new facility is located at 120 Park Ridge Road in Brookfield, covering approximately 141,087 square feet. Once completed, the facility will consolidate operations currently spread across three locations in Danbury and Bethel, Connecticut. The facility is expected to be operational in early 2027, with partial occupancy potentially available by late 2026 if final design and tenant fit-out work proceed smoothly.

2026-08-06

First American Nuclear Company (FANCO) Receives DOE Funding to Accelerate Advanced Nuclear Reactor Development

First American Nuclear Company (FANCO) has received two Rapid Turnaround Experiment (RTE) awards from the U.S. Department of Energy's Office of Nuclear Energy, enabling the company to leverage specialized national laboratory research capabilities to support the development of its EAGL-1 small modular reactor. These awards were granted during the FY2026 RTE selection cycle, which evaluates proposals based on technical superiority, feasibility, and relevance to DOE's nuclear energy programs. The program provides researchers with free access to radiation testing, post-irradiation examination facilities, and technical expertise. FANCO-approved research projects include a study on the effects of extrusion temperature on FeCrAl-ODS alloys in liquid metal fast...

2026-08-06

Nuclea to Explore Building Nuclear Test Reactor in Utah to Advance Morpheus Microreactor Deployment

On August 5, Mangoceuticals announced that Nuclea Energy USA Inc., a wholly owned subsidiary of its merger partner, has signed a memorandum of understanding with the Utah Office of Energy Development to explore siting a nuclear test reactor at the Utah St. Rafael Energy Laboratory to advance the deployment of the Morpheus microreactor. Under the MOU, Nuclea USA and the Utah Office of Energy Development will collaborate on test reactor siting and support related communications and coordination with the U.S. Department of Energy and the U.S. Nuclear Regulatory Commission. The parties will also evaluate pathways for future deployment of Nuclea's technology in Utah. The collaboration is seen as a step in Nuclea's micro modular react...

2026-08-06

Terra Innovatum Selected for Global X Uranium ETF Tracking Nuclear Index, Microreactor SOLO™ Gains Passive Fund Exposure

Terra Innovatum Global N.V. (NASDAQ: NKLR), a Netherlands-registered micro modular reactor developer, will be included in the Solactive Global Uranium & Nuclear Components Total Return Index effective from the market open on August 3, 2026 — the benchmark tracked by the Global X Uranium ETF (NYSE Arca: URA, with over $5 billion in assets under management), taking effect with Solactive's periodic rebalancing. Co-founder and CEO Alessandro Petruzzi stated that this enables passive/thematic investors to directly access its SOLO™ microreactor story through the index, alongside Cameco, Kazatomprom, Centrus, Oklo, NuScale, X-energy, Mitsubishi Heavy Industries, and others in the nuclear fuel cycle and reactor development tier.

2026-08-06

Two Advanced Materials Research Projects by 1st American Nuclear Co. Supported by U.S. Department of Energy Nuclear Science User Facilities Program

1st American Nuclear Co. (FANCO) announced on August 3 that two research proposals submitted by its scientists have been selected for support under the Nuclear Science User Facilities (NSUF) program of the U.S. Department of Energy Office of Nuclear Energy. Both selected projects come from the NSUF Fiscal Year 2026 Rapid Turnaround Experiment (RTE) review cycle, with research focused on next-generation reactor materials and fuel-related issues. The NSUF Rapid Turnaround Experiment program is open to nuclear energy researchers and primarily provides irradiation testing, post-irradiation examination capabilities, and related technical support...

2026-08-06

US Firm Standard Nuclear's Two New TRISO Fuel Plants to Enter Production by 2026, Expanding Independent US Capacity

US nuclear fuel manufacturer Standard Nuclear announced that "major construction is substantially complete" at its two TRISO fuel production facilities, SN-TN in Tennessee and SN-ID in Idaho, and that the US Department of Energy has approved the Preliminary Documented Safety Analysis (PDSA) for both plants. The two facilities share an identical design and are expected to sequentially commence commissioning and licensing before the end of 2026. Authorized under the DOE's "Fuel Line Pilot Program," each plant will initially produce up to 1 metric ton of uranium (MTU) per year of TRISO fuel, with a combined ramp-up target of 5 MTU/year in the long term, forming a tiered supply alongside the company's existing SN-0 facility (0.5 MTU/year) operating in Oak Ridge. Standard Nuclear describes itself as "the only independent TRISO fuel manufacturer in the US," having been restructured from the fuel business of Ultra Safe Nuclear following its bankruptcy in 2024 (with USNC's reactor business acquired by Nano Nuclear). Its operations cover power reactor fuel as well as space and defense radioisotope power sources. The company also participates in the DOE's Fuel Line Pilot and Surplus Plutonium Disposition programs, has been allocated HALEU by the DOE for fuel fabrication, and has established a joint-venture TRISO line at Framatome's NRC-licensed fuel facility in Richland, Washington.

2026-08-06

Trump Administration Revives Spent Fuel Disposal Plan, Seeks State Cooperation

The Trump administration is reshaping spent fuel policy, attempting to restart a long-stalled permanent disposal program through a combination of administrative and legislative measures. This initiative aims to address the growing accumulation of spent fuel, a long-standing issue that has lacked an effective solution. To fund the Nuclear Waste Fund and restore the Department of Energy's access to its $50 billion in resources, the draft legislation proposes reinstating surcharges on nuclear power plants. The core of this policy shift lies in seeking state government participation and cooperation, hoping that states will proactively assume a leading role in spent fuel disposal. While at least two states have already expressed willingness to serve as potential candidate sites, long-time advocates and researchers monitoring the issue warn that significant political resistance and logistical challenges lie ahead.

2026-08-06

Japan's Plutonium Stockpile Expected to Remain at 44.4 Tons by End of 2025

Japan's Cabinet Office reported to the Japan Atomic Energy Commission (JAEC) on August 5 that Japan's plutonium stockpile is expected to be 44.4 tons by the end of 2025, unchanged from the end of the previous year. By source, domestically sourced plutonium stockpile is expected to be 9.9 tons, while overseas-sourced plutonium stockpile is 34.5 tons. The overseas-sourced plutonium mainly comes from separated plutonium formed after Japan entrusted its spent fuel reprocessing operations to the United Kingdom and France. The report shows that in 2024, Kansai Electric Power Company (KEPCO) processed 1.3 tons of plutonium stored in France into mixed uranium-plutonium oxide fuel, namely MOX fuel, resulting in a decrease in overseas-sourced plutonium stockpile. Subsequently, this batch of MOX fuel was shipped to the Takahama Nuclear Power...

2026-08-06

CGN Technology joins forces with enterprises to build China's first fully self-developed electron beam curing coil coating industrial chain

On August 5, CGN Dasheng Accelerator Technology Co., Ltd., a subsidiary of CGN Technology, signed a strategic cooperation agreement on electron beam curing coil coating with Zhejiang Jiaguangshu New Material Technology Co., Ltd. Leveraging the electron accelerator equipment independently developed and manufactured by CGN Dasheng, combined with the partner's large-scale mass production process capabilities, the two parties jointly built China's first fully self-controlled, fully domestically produced complete industrial chain for electron beam curing coil coating, marking the official entry of China's color-coated steel industry into a new era of solvent-free, zero-VOC (volatile organic compounds), room-temperature green curing. CGN Dasheng and Zhejiang Jiaguangshu signed the strategic cooperation agreement on electron beam curing coil coating. Electron beam curing is...

2026-08-06

Romania postpones sinking barges to guide water flow, safeguarding cooling water supply for Cernavodă Nuclear Power Plant

Romania has recently taken emergency measures to address the impact of the persistently declining Danube River water level on the water supply to its nuclear power plant. On August 5 local time, Romanian authorities stated that four barges would be sunk in the Danube River to guide water flow into the water intake channel related to the cooling water supply of the Cernavodă Nuclear Power Plant. Cernavodă is Romania's only nuclear power plant. Affected by drought and the low water level of the Danube, the plant's water intake conditions are under pressure. On August 3, the Romanian military used approximately 180 kilograms of explosives to blast and clear a rock formation in the Danube riverbed, aiming to improve the water flow channel, ensure the cooling water source for units in operation, and prevent the nuclear units from being forced to shut down due to insufficient water supply...

2026-08-06

Han Bing, Chairman of Hefei Municipal CPPCC, Leads Delegation to CYC Ion for Research and Guidance

On the afternoon of August 4, Han Bing, Chairman of Hefei Municipal Committee of the Chinese People's Political Consultative Conference (CPPCC), led a delegation to CYC Ion for research and guidance, and held a symposium. Yong Fengshan, Deputy Director of the Standing Committee of the Municipal People's Congress; Su Xiang, Secretary-General of the Municipal CPPCC; Jiang Xin, Chairman of the Municipal Industrial Investment Group; Zhang Xiaofeng, Director of the Education, Science, Health and Sports Committee of the Municipal CPPCC; and Guo Mei, Deputy Director of the Municipal Bureau of Industry and Information Technology, participated in the event. Song Yuntao, Deputy Director of the Hefei Institutes of Physical Science, Chinese Academy of Sciences; Liu Lu, Chairman of CYC Ion; Chen Yonghua, General Manager; and Deputy General Managers Ding Kaizhong, Li Jun, and Guang Ruohuai accompanied the delegation. The delegation was briefed in detail on CYC Ion's industrial layout and business operations, with discussions focusing on key technological breakthroughs in nuclear medicine and high-end equipment, technology transfer and commercialization, and industrial development.

2026-08-06

CNNC & CIR Co-sponsors Regional Nuclear Medicine Department Development Training Program (Ganzhou Session) and Ganzhou Cancer Hospital High-Quality Nuclear Medicine Diagnosis and Treatment Project Launched Simultaneously

Recently, the Regional Nuclear Medicine Department Development Training Program (Ganzhou Session) and the Ganzhou Cancer Hospital High-Quality Nuclear Medicine Diagnosis and Treatment Project were launched simultaneously at Ganzhou Cancer Hospital. An expert panel from the Nuclear Medicine Branch of the Chinese Medical Association, along with representatives from CNNC & CIR and Atom High-Tech, visited the hospital for research and exchange. More than 200 medical staff from medical institutions at various levels across Jiangxi Province attended the event. The launch ceremony was moderated by Yang Chuansheng, Director of the Nuclear Medicine Department at Ganzhou Cancer Hospital. Fu Wei, Deputy Director of the Ganzhou Municipal Health Commission; Wang Jing, Chair of the Nuclear Medicine Branch of the Chinese Medical Association; and Huang Xingwei, Party Secretary of Ganzhou Cancer Hospital, attended and delivered speeches. Wang Jing stated that nuclear medicine plays a vital supporting role in the precise diagnosis and treatment of major diseases such as cancer, and that promoting the standardized development of regional nuclear medicine at the city and county levels is conducive to channeling high-quality medical resources to the grassroots and enhancing primary healthcare service capabilities.

2026-08-06

CGN Dasheng Joins Hands with Zhejiang Jiaguangshu to Build China's First Fully Self-Developed Electron Beam Curing Coil Steel Coating Industry Chain

On August 5, CGN Dasheng Accelerator Technology Co., Ltd. signed a strategic cooperation agreement on electron beam curing coil steel coating with Zhejiang Jiaguangshu New Material Technology Co., Ltd. Leveraging the electron accelerator equipment independently developed and manufactured by CGN Dasheng, combined with the partner's large-scale mass production process capabilities, the two parties jointly built the first fully self-controllable, fully domestically produced complete industry chain for electron beam curing coil steel coating in China, marking the official entry of China's color coating industry into a new era of solvent-free, zero VOC (volatile organic compounds), and room-temperature green curing. ▲CGN Dasheng and Zhejiang Jiaguangshu sign strategic cooperation agreement on electron beam curing coil steel coating Electron beam curing is a revolutionary new technology for metal coil coating...

2026-08-06